Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Rickman

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Genome Research|November 2, 2010
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencingDorothee Pflueger, Stéphane Terry, Andrea Sboner, et al.
Research Square|February 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Elife|December 13, 2022
Defining cellular population dynamics at single-cell resolution during prostate cancer progressionAlexandre A Germanos, Sonali Arora, Ye Zheng, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and BiomarkersHimisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Genome Research|November 2, 2010
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencingDorothee Pflueger, Stéphane Terry, Andrea Sboner, et al.
Research Square|February 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Elife|December 13, 2022
Defining cellular population dynamics at single-cell resolution during prostate cancer progressionAlexandre A Germanos, Sonali Arora, Ye Zheng, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and BiomarkersHimisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
Pageof 6